Ftse Mib
34.400,99
0,25%
DAX
20.242,57
-0,05%
S&P 500
5.872,16
-2,95%
NASDAQ
19.392,69
-3,56%
Bitcoin
101.281,06
1,22%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IRIDEX Corporation (IRIX) IRIDEX Corporation (IRIX) Notizie

IRIDEX Corporation

IRIX
1,9987
0,3187 (18,97%)
19 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202422:05GLOBEIridex Announces Milestone Five-Year Study Confirms the..
19/11/202414:14GLOBEIridex Comments on Changing Glaucoma Reimbursement Landscape
13/11/202423:20EDGAR2Form 8-K - Current report
12/11/202422:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:19EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEIridex Reports Third Quarter 2024 Financial Results
09/11/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202422:05GLOBEIridex to Report Third Quarter 2024 Financial Results on..
03/10/202423:04EDGAR2Form 8-K - Current report
03/10/202422:05GLOBEIridex Appoints Patrick Mercer as Chief Executive Officer
25/9/202422:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/9/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/9/202412:09EDGAR2Form 8-K - Current report
05/9/202422:04EDGAR2Form S-3 - Registration statement under Securities Act of..
08/8/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:11EDGAR2Form 8-K - Current report
08/8/202422:05GLOBEIridex Reports Second Quarter 2024 Financial Results
05/8/202415:25EDGAR2Form 8-K - Current report
05/8/202414:00GLOBEIridex Announces Convertible Note Financing
30/7/202422:05GLOBEIridex to Report Second Quarter 2024 Financial Results on..
08/7/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202419:07EDGAR2Form SD - Specialized disclosure report
31/5/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:11EDGAR2Form 8-K - Current report
14/5/202423:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:28EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEIridex Reports First Quarter 2024 Financial Results
08/5/202422:05GLOBEIridex to Report First Quarter 2024 Financial Results on May..
26/3/202421:05GLOBEIridex Reports Fourth Quarter and Full Year 2023 Financial..
20/3/202421:05GLOBEIridex Schedules Fourth Quarter and Full Year 2023 Financial..
06/2/202414:00GLOBEIridex Corporation Receives European Patent on MicroPulse..
24/1/202414:00GLOBEIridex Announces First Patient Enrollment in MicroPulse® TLT..
12/1/202400:45GLOBEIridex Launches New Iridex 532® and Iridex 577® Lasers in US..
29/12/202300:00GLOBEIridex Confirms Medicare Administrative Contractors Retired..
Apertura: 1,72 Min: 1,64 Max: 1,78
Chiusura: 1,68

La tua Cronologia

NASDAQ
IRIX
IRIDEX
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network